STOCK MARKET BSE NSE

Centre allocating less funds for Siddha medicine research, fumes HC

“While about Rs 3,000 crore was allocated for Ayurveda research, only Rs 437 crore was provided for Siddha research in the past 10 years.

Published: 21st August 2020 03:24 AM  |   Last Updated: 21st August 2020 03:24 AM   |  A+A-

Madras High Court

Madras High Court (File photo | EPS)

By Express News Service

CHENNAI: The Central government has been meting out step-motherly treatment towards Siddha medicine research with regard to fund allocation, the Madras High Court on Thursday observed.

The bench of judges N Kirubakaran and VM Velumani was hearing the bail plea of Siddha doctor Thiruthanikachalam, who was detained under the Goondas Act for claiming to have found a cure for Covid-19.

“While about Rs 3,000 crore was allocated for Ayurveda research, only Rs 437 crore was provided for Siddha research in the past 10 years. This cannot be tolerated,” the bench observed and directed the Assistant Solicitor General of India G Karthikeyan to state the reason for such low allocation of funds within a week. The judges made the observations after the Ayush Ministry filed a report on the fund allocation for research.

Bail plea hearing
The High Court was hearing the bail plea of Siddha doctor Thiruthanikachalam, who was detained under the Goondas Act for claiming to have found a cure for Covid-19.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp